Clinical trial
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED…
NCT00116584 · University of Louisville, Other · Completed
Key facts
| NCT number | NCT00116584 |
|---|---|
| Title | Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients |
| Official title | The Use of Heliox Driven Racemic Epinephrine Nebulization in the Treatment of Moderate to Severe Bronchiolitis in Pediatric Emergency Department Patients |
| Lead sponsor | University of Louisville, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchiolitis |
| Intervention type | Drug |
| Interventions | heliox, oxygen |
| Enrollment | 72 |
| Start date | Dec 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Oct 1, 2011 |
| First posted | Jun 30, 2005 |
| Last update posted | May 20, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: